Sanofi SA (NASDAQ:SNY)
| 51.55 Delayed Data As of Jun 08 |  +0.67 / +1.32%Today’s Change | 36.91 Today|||52-Week Range 57.82 | +6.44% Year-to-Date |
Latest SNY News | Press Releases
Today’s Trading
| Previous close | 50.88 |
| Today’s open | 51.14 |
| Day’s range | 51.03 - 51.60 |
| Volume | 45,045 |
| Average volume (3 months) | 1,709,478 |
| Market cap | $128.1B |
Data as of 3:59pm ET, 06/08/2023
Growth & Valuation
| Earnings growth (last year) | +19.66% |
| Earnings growth (this year) | -0.06% |
| Earnings growth (next 5 years) | +7.00% |
| Revenue growth (last year) | +1.25% |
| P/E ratio | 14.4 |
| Price/Sales | 2.69 |
| Price/Book | 1.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BMYBristol-Myers Squibb | +0.15 | +0.23% |
| VRTXVertex Pharmaceutica... | +7.89 | +2.43% |
| REGNRegeneron Pharmaceut... | +11.59 | +1.57% |
| ---- |
Data as of 4:00pm ET, 06/08/2023
Financials
| Next reporting date | July 28, 2023 |
| EPS forecast (this quarter) | $0.89 |
| Annual revenue (last year) | $45.2B |
| Annual profit (last year) | $8.8B |
| Net profit margin | 19.47% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Paris, Ile-de-france |
Forecasts
